INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,000 | -37.5% | 1,100 | 0.0% | 0.00% | – |
Q3 2021 | $8,000 | -20.0% | 1,100 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
Q1 2021 | $10,000 | – | 1,100 | – | 0.00% | – |
Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2017 | $16,000 | +23.1% | 2,000 | 0.0% | 0.00% | – |
Q1 2017 | $13,000 | -7.1% | 2,000 | 0.0% | 0.00% | – |
Q4 2016 | $14,000 | -26.3% | 2,000 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $19,000 | +5.6% | 2,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $18,000 | -52.6% | 2,000 | -54.5% | 0.00% | 0.0% |
Q1 2016 | $38,000 | +100.0% | 4,400 | +51.7% | 0.00% | 0.0% |
Q4 2015 | $19,000 | – | 2,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |